Author:
Wenners Antonia,Grambach Jana,Koss Juliane,Maass Nicolai,Jonat Walter,Schmutzler Andreas,Mundhenke Christoph
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference41 articles.
1. JW PE, Fink D, Köchli O, editors. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer-Verlag Berlin; 2011.
2. Clarke MJ. WITHDRAWN: multi-agent chemotherapy for early breast cancer. Cochrane Database Syst Rev. 2008;4:CD000487.
3. Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771–84.
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717.
5. Castiglione-Gertsch M, O'Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst. 2003;95(24):1833–46.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献